blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1532154

EP1532154 - THIENO-PYRROLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.11.2008
Database last updated on 05.07.2024
Most recent event   Tooltip29.10.2010Lapse of the patent in a contracting state
New state(s): GR
published on 01.12.2010  [2010/48]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2005/21]
Inventor(s)01 / Arnould, Jean Claude
AstraZeneca R & D Reims, Z.I. la Pompelle, BP 1050
Cedex 2, 51689 Reims / FR
 [2005/21]
Application number, filing date03748242.918.08.2003
[2005/21]
WO2003GB03603
Priority number, dateEP2002029207621.08.2002         Original published format: EP 02292076
[2005/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004018479
Date:04.03.2004
Language:EN
[2004/10]
Type: A1 Application with search report 
No.:EP1532154
Date:25.05.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.2004 takes the place of the publication of the European patent application.
[2005/21]
Type: B1 Patent specification 
No.:EP1532154
Date:16.01.2008
Language:EN
[2008/03]
Search report(s)International search report - published on:EP04.03.2004
ClassificationIPC:C07D495/04, A61K31/40, A61P35/00
[2007/34]
CPC:
C07D495/04 (EP,US); A61P15/00 (EP); A61P35/00 (EP);
A61P5/24 (EP)
Former IPC [2005/21]C07D495/04, A61K31/40, A61P35/00, // (C07D495/04, 333:00), C07D209:00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/21]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:THIENO-PYRROLE VERBINDUNGEN ALS ANTAGONISTEN DER GONADOTROPIN-FREISETZENDEN HORMONREZEPTOREN[2005/21]
English:THIENO-PYRROLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE[2005/21]
French:COMPOSES DE THIENO-PYRROLE UTILISES COMME ANTAGONISTES DE L'HORMONE DE LIBERATION DE GONADOTROPHINE[2005/21]
Entry into regional phase21.03.2005National basic fee paid 
21.03.2005Designation fee(s) paid 
21.03.2005Examination fee paid 
Examination procedure13.02.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.03.2005Examination requested  [2005/21]
12.09.2006Despatch of a communication from the examining division (Time limit: M04)
17.01.2007Reply to a communication from the examining division
07.02.2007Despatch of a communication from the examining division (Time limit: M04)
25.05.2007Reply to a communication from the examining division
23.07.2007Communication of intention to grant the patent
03.12.2007Fee for grant paid
03.12.2007Fee for publishing/printing paid
Opposition(s)17.10.2008No opposition filed within time limit [2008/52]
Fees paidRenewal fee
31.08.2005Renewal fee patent year 03
31.08.2006Renewal fee patent year 04
31.08.2007Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.01.2008
BE16.01.2008
CY16.01.2008
CZ16.01.2008
DK16.01.2008
EE16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
TR16.01.2008
BG16.04.2008
GR17.04.2008
PT16.06.2008
HU17.07.2008
IE18.08.2008
LU18.08.2008
MC31.08.2008
[2010/48]
Former [2010/37]AT16.01.2008
BE16.01.2008
CY16.01.2008
CZ16.01.2008
DK16.01.2008
EE16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
TR16.01.2008
BG16.04.2008
PT16.06.2008
HU17.07.2008
IE18.08.2008
LU18.08.2008
MC31.08.2008
Former [2010/34]AT16.01.2008
BE16.01.2008
CY16.01.2008
CZ16.01.2008
DK16.01.2008
EE16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
BG16.04.2008
PT16.06.2008
HU17.07.2008
IE18.08.2008
LU18.08.2008
MC31.08.2008
Former [2010/32]AT16.01.2008
BE16.01.2008
CY16.01.2008
CZ16.01.2008
DK16.01.2008
EE16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
BG16.04.2008
PT16.06.2008
IE18.08.2008
LU18.08.2008
MC31.08.2008
Former [2009/34]AT16.01.2008
BE16.01.2008
CY16.01.2008
CZ16.01.2008
DK16.01.2008
EE16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
BG16.04.2008
PT16.06.2008
IE18.08.2008
MC31.08.2008
Former [2009/22]AT16.01.2008
BE16.01.2008
CZ16.01.2008
DK16.01.2008
EE16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
BG16.04.2008
PT16.06.2008
MC31.08.2008
Former [2009/18]AT16.01.2008
BE16.01.2008
CZ16.01.2008
DK16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
BG16.04.2008
PT16.06.2008
MC31.08.2008
Former [2008/50]AT16.01.2008
BE16.01.2008
CZ16.01.2008
DK16.01.2008
FI16.01.2008
NL16.01.2008
RO16.01.2008
SI16.01.2008
SK16.01.2008
BG16.04.2008
PT16.06.2008
Former [2008/46]AT16.01.2008
BE16.01.2008
DK16.01.2008
FI16.01.2008
NL16.01.2008
SI16.01.2008
BG16.04.2008
PT16.06.2008
Former [2008/44]AT16.01.2008
BE16.01.2008
FI16.01.2008
NL16.01.2008
SI16.01.2008
BG16.04.2008
PT16.06.2008
Former [2008/43]AT16.01.2008
BE16.01.2008
FI16.01.2008
NL16.01.2008
BG16.04.2008
PT16.06.2008
Former [2008/42]AT16.01.2008
FI16.01.2008
NL16.01.2008
BG16.04.2008
PT16.06.2008
Former [2008/39]AT16.01.2008
FI16.01.2008
NL16.01.2008
BG16.04.2008
Former [2008/27]NL16.01.2008
Cited inInternational search[AD]WO9941251  (MERCK & CO INC [US], et al) [AD] 1-15 * claims 1,4 *;
 [A]US6025366  (WALSH THOMAS F [US], et al) [A] 1-15 * claims 1,4 *;
 [AD]WO0053185  (MERCK & CO INC [US], et al) [AD] 1-15 * claims 1,4 *;
 [A]WO0170227  (MERCK & CO INC [US], et al) [A] 1-15 * claims 1,6 *;
 [A]US6340686  (FURUYA SHUICHI [JP], et al) [A] 1-15 * claims 1,15 *;
 [PAD]WO02092565  (ASTRAZENECA AB [SE], et al) [PAD] 1-15* claims 1,11 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.